176 related articles for article (PubMed ID: 37820086)
21. Intrathecal Trastuzumab Treatment in Patients with Breast Cancer and Leptomeningeal Carcinomatosis.
Park WY; Kim HJ; Kim K; Bae SB; Lee N; Lee KT; Won JH; Park HS; Lee SC
Cancer Res Treat; 2016 Apr; 48(2):843-7. PubMed ID: 25761487
[TBL] [Abstract][Full Text] [Related]
22. Leptomeningeal carcinomatosis: easy to miss.
Sekhar A; Corbo B; Das K; Biswas S
J R Coll Physicians Edinb; 2017 Dec; 47(4):351-352. PubMed ID: 29537406
[TBL] [Abstract][Full Text] [Related]
23. Leptomeningeal disease.
Groves MD
Neurosurg Clin N Am; 2011 Jan; 22(1):67-78, vii. PubMed ID: 21109151
[TBL] [Abstract][Full Text] [Related]
24. Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.
Mego M; Sycova-Mila Z; Obertova J; Rajec J; Liskova S; Palacka P; Porsok S; Mardiak J
Breast; 2011 Oct; 20(5):478-80. PubMed ID: 21700455
[TBL] [Abstract][Full Text] [Related]
25. Breast brain metastases are associated with increased risk of leptomeningeal disease after stereotactic radiosurgery: a systematic review and meta-analysis.
Brown DA; Lu VM; Himes BT; Burns TC; Quiñones-Hinojosa A; Chaichana KL; Parney IF
Clin Exp Metastasis; 2020 Apr; 37(2):341-352. PubMed ID: 31950392
[TBL] [Abstract][Full Text] [Related]
26. Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment era.
Remon J; Le Rhun E; Besse B
Cancer Treat Rev; 2017 Feb; 53():128-137. PubMed ID: 28110254
[TBL] [Abstract][Full Text] [Related]
27. ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases.
Kumthekar P; Tang SC; Brenner AJ; Kesari S; Piccioni DE; Anders C; Carrillo J; Chalasani P; Kabos P; Puhalla S; Tkaczuk K; Garcia AA; Ahluwalia MS; Wefel JS; Lakhani N; Ibrahim N
Clin Cancer Res; 2020 Jun; 26(12):2789-2799. PubMed ID: 31969331
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy and Security of Intrathecal with Methotrexate in the Treatment of Meningeal Carcinomatosis].
Wu X; Li J; Xiao J; Yang B; Yu L; Wu X; Wan J; Xu H; Kong J
Zhongguo Fei Ai Za Zhi; 2016 May; 19(5):252-6. PubMed ID: 27215452
[TBL] [Abstract][Full Text] [Related]
29. Leptomeningeal carcinomatosis in esophageal cancer: a case series and systematic review of the literature.
Lukas RV; Mata-Machado NA; Nicholas MK; Salgia R; Antic T; Villaflor VM
Dis Esophagus; 2015; 28(8):772-81. PubMed ID: 25142531
[TBL] [Abstract][Full Text] [Related]
30. Craniospinal irradiation in the treatment of chemotherapy refractory leptomeningeal metastasis from breast cancer: A case report.
Tesolin D; Vergidis D; Ramchandar K
Cancer Rep (Hoboken); 2022 Jul; 5(7):e1556. PubMed ID: 34761557
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe.
Le Rhun E; Rudà R; Devos P; Hoang-Xuan K; Brandsma D; Pérez Segura P; Soffietti R; Weller M
J Neurooncol; 2017 Jun; 133(2):419-427. PubMed ID: 28455788
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes of breast leptomeningeal disease treated with intrathecal trastuzumab, intrathecal chemotherapy, or whole brain radiation therapy.
Figura NB; Rizk VT; Mohammadi H; Evernden B; Mokhtari S; Yu HM; Robinson TJ; Etame AB; Tran ND; Liu J; Washington I; Diaz R; Czerniecki BJ; Soliman H; Han HS; Sahebjam S; Forsyth PA; Ahmed KA
Breast Cancer Res Treat; 2019 Jun; 175(3):781-788. PubMed ID: 30859348
[TBL] [Abstract][Full Text] [Related]
34. Leptomeningeal Metastases: New Opportunities in the Modern Era.
Wilcox JA; Li MJ; Boire AA
Neurotherapeutics; 2022 Oct; 19(6):1782-1798. PubMed ID: 35790709
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic and Therapeutic Updates in Leptomeningeal Disease.
Roy-O'Reilly MA; Lanman T; Ruiz A; Rogawski D; Stocksdale B; Nagpal S
Curr Oncol Rep; 2023 Aug; 25(8):937-950. PubMed ID: 37256537
[TBL] [Abstract][Full Text] [Related]
36. Intrathecal therapy for the management of leptomeningeal metastatic disease: a scoping review of the current literature and ongoing clinical trials.
Palmisciano P; Watanabe G; Conching A; Ogasawara C; Vojnic M; D'Amico RS
J Neurooncol; 2022 Oct; 160(1):79-100. PubMed ID: 35999434
[TBL] [Abstract][Full Text] [Related]
37. Effects of Postoperative Radiotherapy on Leptomeningeal Carcinomatosis or Dural Metastasis after Resection of Brain Metastases in Breast Cancer Patients.
Ha B; Chung SY; Kim YJ; Gwak HS; Chang JH; Lee SH; Park IH; Lee KS; Lee S; Kim TH; Kim DY; Kang SG; Suh CO
Cancer Res Treat; 2017 Jul; 49(3):748-758. PubMed ID: 27809457
[TBL] [Abstract][Full Text] [Related]
38. Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience.
Kingston B; Kayhanian H; Brooks C; Cox N; Chaabouni N; Redana S; Kalaitzaki E; Smith I; O'Brien M; Johnston S; Parton M; Noble J; Stanway S; Ring A; Turner N; Okines A
Breast; 2017 Dec; 36():54-59. PubMed ID: 28968585
[TBL] [Abstract][Full Text] [Related]
39. [Effective systemic palliative chemotherapy for intracranial metastases of breast cancer].
Sipőcz I; Pintér T; Skaliczky Z; Kullmann T
Orv Hetil; 2016 Nov; 157(45):1809-1813. PubMed ID: 27817234
[TBL] [Abstract][Full Text] [Related]
40. Autocrine GMCSF Signaling Contributes to Growth of HER2
Ansari KI; Bhan A; Saotome M; Tyagi A; De Kumar B; Chen C; Takaku M; Jandial R
Cancer Res; 2021 Sep; 81(18):4723-4735. PubMed ID: 34247146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
